Investments†—73.9% | | Investment Type | | | Acquisition Date | | Cost | | Fair Value |
Direct Investments—50.3% |
Direct Equity—32.0% |
Germany—3.7% |
Information Technology—3.7% |
Fremman 1 MM Co-investment 7 Rocket SCSp*(1)(2)(3)(4)(5) | | Limited Partnership Interest | 02/13/2024 | | $ 951,727 | | $ 893,415 |
Luxembourg—4.1% |
Information Technology—4.1% |
Stirling Square Capital Partners Eagle Co-Investment SCSp*(2)(3)(4)(5) | | Limited Partnership Interest | 11/13/2023 | | 1,012,232 | | 1,004,480 |
United States—24.2% |
Consumer Discretionary—4.7% |
BPCP NSA Holdings, Inc. Class A Preferred Stock, 8.00%*(1)(2)(4)(5)(6) | | Preferred Stock | 05/15/2024 | | 858,275 | | 858,275 |
BPCP NSA Holdings, Inc. Common Stock*(1)(2)(4)(5) | | Common Stock | 05/15/2024 | | 286,091 | | 286,091 |
Health Care—7.2% |
Resurgens II Co-Invest C, L.P.*(2)(3)(4)(5) | | Limited Partnership Interest | 11/15/2023 | | 656,895 | | 652,974 |
NanoVista*(1)(2)(3)(4)(5) | | Limited Partnership Interest | 04/23/2024 | | 1,145,300 | | 1,111,253 |
Information Technology—5.3% |
Chronos Capital Fund, L.P.*(1)(2)(3)(4)(5) | | Limited Partnership Interest | 04/29/2024 | | 1,125,606 | | 1,301,189 |
Utilities—7.0% |
Greenbelt Capital Partners Saber L.P.*(1)(2)(4)(5) | | Limited Partnership Interest | 10/25/2023 | | 1,250,000 | | 1,701,074 |
| | | | | | | 7,286,126 | | 7,808,751 |
Secondary Direct Equity—18.3% |
Luxembourg—4.1% |
Health Care—4.1% |
Ourvita Build-Up SCSp*(1)(2)(3)(4)(5) | | Limited Partnership Interest | 11/16/2023 | | 723,297 | | 1,002,150 |
United States—14.2% |
Industrials—9.0% |
VSC EV3 (Parallel) LP*(1)(2)(3)(4)(5) | | Limited Partnership Interest | 12/19/2023 | | 734,376 | | 923,431 |
TRP Continuation Fund (Genox), LP*(1)(2)(3)(4)(5) | | Limited Partnership Interest | 02/22/2024 | | 1,095,745 | | 1,263,026 |
Health Care—5.2% |
KL Champion Blocker PI LLC*(1)(2)(4)(5) | | Limited Partnership Interest | 05/01/2024 | | 1,250,000 | | 1,272,359 |
| | | | | | | 3,803,418 | | 4,460,966 |